
-
1998
Company Description
Resistentia Pharmaceuticals develops immunotherapeutic products for allergic asthma and inflammatory disorders.
Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiple sclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.
-
Manufacturer:
Science and Engineering -
Formed:
1998 -
Company Website:
-
Company E-mail:
-
Company Address:
SwedenKungsängsvägen 25 -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits